Vanda Pharmaceuticals Inc (VNDA) Insider Trading
- $12,400,431.92
- $51,766,068.56
- Nov. 14, 2024
- Mihael Hristos Polymeropoulos
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 14, 2024 | Director | 5,000 | $5.17 | Sell | $25,850.00 | |
July 29, 2024 | CFO | 2,251 | $5.92 | Sell | $13,325.92 | |
Aug. 21, 2023 | CMO | 3,724 | $5.84 | Sell | $21,748.16 | |
Aug. 10, 2023 | Director | 6,500 | $6.05 | Sell | $39,325.00 | |
July 28, 2023 | CFO | 2,212 | $6.30 | Sell | $13,935.60 | |
June 15, 2023 | CFO | 16,000 | $6.29 | Sell | $100,640.00 | |
June 13, 2023 | SVP | 14,600 | $6.56 | Sell | $95,776.00 | |
March 2, 2023 | SVP | 8,437 | $6.24 | Sell | $52,646.88 | |
March 2, 2023 | CMO | 7,720 | $6.23 | Sell | $48,095.60 | |
March 2, 2023 | CEO | 22,426 | $6.23 | Sell | $139,713.98 | |
March 2, 2023 | CFO | 7,966 | $6.26 | Sell | $49,867.16 | |
Dec. 15, 2022 | SVP | 8,000 | $7.01 | Sell | $56,080.00 | |
Dec. 6, 2022 | CFO | 4,792 | $10.61 | Sell | $50,843.12 | |
Dec. 5, 2022 | CEO | 47,650 | $10.62 | Sell | $506,043.00 | |
Aug. 22, 2022 | CMO | 3,605 | $10.27 | Sell | $37,023.35 | |
July 28, 2022 | CFO | 2,239 | $10.97 | Sell | $24,561.83 | |
June 13, 2022 | Director | 2,700 | $9.48 | Sell | $25,596.00 | |
May 31, 2022 | Director | 6,500 | $9.85 | Sell | $64,025.00 | |
March 2, 2022 | CMO | 6,974 | $11.19 | Sell | $78,039.06 | |
March 2, 2022 | SVP | 12,060 | $11.09 | Sell | $133,745.40 | |
March 1, 2022 | CEO | 7,508 | $11.19 | Sell | $84,014.52 | |
March 1, 2022 | CFO | 3,473 | $11.19 | Sell | $38,862.87 | |
Dec. 1, 2021 | CEO | 46,200 | $16.00 | Sell | $739,200.00 | |
Sept. 15, 2021 | Insider | 16,824 | $16.49 | Sell | $277,427.76 | |
Sept. 9, 2021 | Director | 19,109 | $16.74 | Sell | $319,884.66 | |
Aug. 20, 2021 | CMO | 3,650 | $15.39 | Sell | $56,173.50 | |
July 28, 2021 | CFO | 2,130 | $19.24 | Sell | $40,981.20 | |
July 26, 2021 | Insider | 7,250 | $19.69 | Sell | $142,752.50 | |
June 14, 2021 | Director | 2,075 | $19.34 | Sell | $40,130.50 | |
March 15, 2021 | Insider | 18,000 | $17.72 | Sell | $318,960.00 | |
March 8, 2021 | CEO | 175,000 | $18.00 | Sell | $3,150,000.00 | |
March 5, 2021 | SVP | 5,600 | $17.85 | Sell | $99,960.00 | |
March 2, 2021 | SVP | 20,465 | $18.28 | Sell | $374,100.20 | |
Feb. 16, 2021 | Director | 5,818 | $18.54 | Sell | $107,865.72 | |
Dec. 15, 2020 | CEO | 125,252 | $13.04 | Sell | $1,633,286.08 | |
Aug. 20, 2020 | CMO | 3,710 | $11.08 | Sell | $41,106.80 | |
Aug. 14, 2020 | SVP | 3,684 | $11.81 | Sell | $43,508.04 | |
July 27, 2020 | Insider | 7,313 | $10.62 | Sell | $77,664.06 | |
May 28, 2020 | Director | 10,129 | $11.04 | Sell | $111,824.16 | |
Jan. 2, 2020 | CFO | 4,020 | $15.94 | Sell | $64,078.80 | |
Jan. 2, 2020 | SVP | 1,155 | $16.06 | Sell | $18,549.30 | |
Jan. 2, 2020 | CEO | 9,467 | $16.00 | Sell | $151,472.00 | |
Aug. 26, 2019 | Director | 15,000 | $14.85 | Sell | $222,750.00 | |
Aug. 14, 2019 | SVP | 2,575 | $14.69 | Sell | $37,826.75 | |
May 21, 2019 | CEO | 72,872 | $15.34 | Sell | $1,117,856.48 | |
May 17, 2019 | CEO | 77,225 | $15.56 | Sell | $1,201,621.00 | |
March 4, 2019 | CFO | 8,751 | $19.88 | Sell | $173,969.88 | |
March 4, 2019 | CEO | 38,166 | $19.41 | Sell | $740,802.06 | |
March 4, 2019 | SVP | 443 | $19.92 | Sell | $8,824.56 | |
March 1, 2019 | SVP | 438 | $20.17 | Sell | $8,834.46 |
Insiders are both buying and selling Vanda Pharmaceuticals Inc stock.
The insider traders at Vanda Pharmaceuticals Inc are: Mihael Hristos Polymeropoulos, Kevin Patrick Moran, Timothy Williams, James Patrick Kelly, Joakim Wijkstrom, Aranthan Jones II, Gian Piero Reverberi, James E Flynn, Richard W Dugan, Stephen Ray Mitchell, Gunther Birznieks, Thomas Watkins, Richard L Gulino, Robert Repella, Paolo Baroldi, and Phaedra Chrousos
The most active insider trader at Vanda Pharmaceuticals Inc is Mihael Hristos Polymeropoulos with 17 trades.
James E Flynn has sold the most Vanda Pharmaceuticals Inc stock with a total value of $45,689,563.08.
James E Flynn has bought the most Vanda Pharmaceuticals Inc stock with a total value of $22,467,862.24.
The most recent insider trade for Vanda Pharmaceuticals Inc was on Nov. 14, 2024.
The single biggest insider buy for Vanda Pharmaceuticals Inc was from James E Flynn with a total value of $10,067,430.32 on Dec. 11, 2015.
The single biggest insider sell for Vanda Pharmaceuticals Inc was from James E Flynn with a total value of $18,554,834.16 on Sept. 23, 2016.